WEST PHARMACEUTICAL SERVICES INC cotiza a 371.82 USD y tiene una capitalización bursátil de $26.2B. En los últimos 12 meses ha facturado $3.3B con un margen de flujo de caja libre del 15.3%. Cotiza a 59.9 veces su flujo de caja libre (P/FCF) y a un PER de 46.3. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary …
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $2.37 | $2.13 | $2.04 |
| Estimado | $2.20 | $2.08 | $1.68 | $1.83 |
| Sorpresa | — | +13.9% | +26.8% | +11.5% |
| Métrica | WST | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 35.9% | 57.0% | -21.1% |
| Operating Margin | 19.0% | -38.6% | +57.6% |
| Net Margin | 16.1% | -33.6% | +49.6% |
| FCF Margin | 15.3% | -13.9% | +29.1% |
| ROE | 15.5% | -40.4% | +55.9% |
| ROA | 11.6% | -32.0% | +43.6% |
| Current Ratio | 3.02 | 2.84 | +0.18 |
| Debt / Equity | 0.06 | 0.28 | -0.22 |